Cabot Co. (NYSE:CBT) Shares Purchased by Fox Run Management L.L.C.

Fox Run Management L.L.C. raised its position in Cabot Co. (NYSE:CBTFree Report) by 27.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 5,904 shares of the specialty chemicals company’s stock after acquiring an additional 1,259 shares during the quarter. Fox Run Management L.L.C.’s holdings in Cabot were worth $539,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CBT. R Squared Ltd purchased a new position in shares of Cabot in the fourth quarter valued at $26,000. EverSource Wealth Advisors LLC increased its position in Cabot by 37.2% during the 4th quarter. EverSource Wealth Advisors LLC now owns 808 shares of the specialty chemicals company’s stock worth $74,000 after purchasing an additional 219 shares in the last quarter. GAMMA Investing LLC raised its stake in Cabot by 10.7% in the 4th quarter. GAMMA Investing LLC now owns 1,348 shares of the specialty chemicals company’s stock valued at $123,000 after purchasing an additional 130 shares during the last quarter. Manchester Capital Management LLC lifted its holdings in Cabot by 1,685.1% in the 4th quarter. Manchester Capital Management LLC now owns 1,678 shares of the specialty chemicals company’s stock valued at $153,000 after purchasing an additional 1,584 shares in the last quarter. Finally, KBC Group NV boosted its stake in shares of Cabot by 43.1% during the 4th quarter. KBC Group NV now owns 2,046 shares of the specialty chemicals company’s stock worth $187,000 after purchasing an additional 616 shares during the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

Shares of CBT stock opened at $84.00 on Wednesday. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.29 and a current ratio of 2.00. The firm has a market capitalization of $4.55 billion, a price-to-earnings ratio of 11.16, a price-to-earnings-growth ratio of 0.74 and a beta of 1.21. Cabot Co. has a one year low of $79.57 and a one year high of $117.46. The company has a 50 day moving average price of $86.17 and a 200 day moving average price of $98.51.

Cabot (NYSE:CBTGet Free Report) last released its quarterly earnings data on Monday, February 3rd. The specialty chemicals company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.74 by $0.02. Cabot had a return on equity of 26.79% and a net margin of 10.60%. Sell-side analysts anticipate that Cabot Co. will post 7.57 EPS for the current year.

Cabot declared that its Board of Directors has authorized a share repurchase plan on Tuesday, December 3rd that allows the company to buyback 10,000,000 outstanding shares. This buyback authorization allows the specialty chemicals company to purchase shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.

Cabot Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 14th. Stockholders of record on Friday, February 28th were issued a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.05%. The ex-dividend date was Friday, February 28th. Cabot’s payout ratio is currently 22.84%.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the stock. StockNews.com lowered shares of Cabot from a “buy” rating to a “hold” rating in a research report on Tuesday, March 11th. JPMorgan Chase & Co. cut their price target on Cabot from $105.00 to $85.00 and set an “underweight” rating for the company in a report on Friday, February 21st. Finally, Mizuho decreased their price objective on Cabot from $122.00 to $110.00 and set an “outperform” rating on the stock in a report on Tuesday, January 7th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $97.00.

Check Out Our Latest Report on Cabot

Cabot Profile

(Free Report)

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.

Further Reading

Want to see what other hedge funds are holding CBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cabot Co. (NYSE:CBTFree Report).

Institutional Ownership by Quarter for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.